Tag: cx symposium
New randomized controlled data from VenaSeal Spectrum Program reinforces evidence that...
“The initial results of two of the three studies in the VenaSeal Spectrum Program reinforce the safety and effectiveness of the VenaSeal system as...
Manj Gohel
“As I learned more about venous pathologies, it became abundantly clear that patients with venous disease were a largely neglected population in need of...
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82....
CX 2020 LIVE: Overwhelming 91% of specialist audience favours venous stents
A poll of an enthused audience of venous specialists during the CX 2020 LIVE Deep Venous Disease Consensus session found that 91% of them were in...
CX 2020 LIVE addresses latest developments in superficial venous disease
For the first venous session of CX 2020 LIVE, 759 attendees from 79 different countries tuned in. Each audience member could submit their name,...
CX 2020 is cancelled due to COVID-19
The 2020 Charing Cross (CX) Symposium that was due to take place next month in London, UK, has been cancelled due to COVID-19.
In full,...
The optimal pathway for acute deep vein thrombosis treatment involves identification,...
Prakash Saha (London, UK), speaking during the Venous and Lymphatic Challenges programme at CX (15–18 April, London, UK), outlined the three key steps to...